Payers need to reframe how they view obesity as not just a health and wellness issue, but as a progressive chronic disease that needs medication, explained David Skomo, RPh, chief operations officer at WellDyne.
Over 70% of U.S. adults are struggling with their weight, and obesity is linked to 60 comorbidities, noted David Skomo, RPh, chief pharmacy operations officer, WellDyne. Given the growing obesity problem, payers need to reframe how they view the disease as not just a health and wellness issue, but as a progressive chronic disease that needs medication.
Skomo presented on coverage of obesity treatments on the last day of the 2022 PBMI Annual National Conference in Orlando, Florida.
Michael Thompson on Employer-PBM Relations and What It Will Take to Change Them
September 12th 2023Thompson, the president of the National Alliance of Healthcare Purchaser Coalitions, said if that 20% of the market changes way it deals with PBMs “it will change the market, it will change the conversation, it will change the practices of key players.”
Read More